How do I find out if I qualify for a juvenile myelomonocytic leukemia study in Minnesota?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Minnesota to take part?

Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a juvenile myelomonocytic leukemia trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Minnesota

Juvenile Myelomonocytic Leukemia clinical trials in Minnesota

We’re tracking 4 recruiting juvenile myelomonocytic leukemia studies with a site in Minnesota — including Phase 1, Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Minnesota

NCT04726241RecruitingPhase 1/Phase 2
Testing blood and bone marrow samples in young leukemia patients
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
Minneapolis, MinnesotaAges Up to 22 years
NCT05735717RecruitingPhase 2
T-cell transplant using depleted receptors for blood cancers
This Phase 2 study tests a specialized stem cell transplant that removes certain immune “T-cell” receptors to help treat blood cancers like acute leukemia. It may help your body rebuild a healthier immune system after high-dose treatment.
Minneapolis, MinnesotaAges Up to 60 years
NCT06247787RecruitingPhase 1
Imetelstat plus chemo for relapsed leukemia in kids
This trial tests a new drug called imetelstat combined with two chemotherapy drugs (fludarabine and cytarabine) for children and teens with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or juvenile myelomonocytic leukemia (JMML) that has come back or not responded to treatment. The goal is to find the safest dose of imetelstat and see if it helps control the cancer.
Minneapolis, MinnesotaAges 1–18
NCT03314974RecruitingPhase 2
Stem cell transplant study for blood cancers
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
Minneapolis, MinnesotaAges Up to 60 years

Juvenile Myelomonocytic Leukemia trials by city in Minnesota

Minneapolis–St. Paul

Where these studies are running in Minnesota

Institutions with a site for the recruiting juvenile myelomonocytic leukemia studies listed above.

University of Minnesota Masonic Cancer Center · 4 studies
Children's Hospitals and Clinics of Minnesota - Minneapolis
Mayo Clinic

What taking part in a juvenile myelomonocytic leukemia study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Common questions

Are there juvenile myelomonocytic leukemia clinical trials in Minnesota?: Yes. We're currently tracking 4 recruiting juvenile myelomonocytic leukemia studies with a site in Minnesota, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a juvenile myelomonocytic leukemia study in Minnesota?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Minnesota to take part?: Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a juvenile myelomonocytic leukemia trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New juvenile myelomonocytic leukemia studies open in Minnesota regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.